ArticleOncoimmunology2015

A clinical trial of multiple peptides vaccination for advanced head and neck cancer patients induced immune responses and prolonged OS.

Yoshihiro Yoshitake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.